The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
about
Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stressAssociation of pesticide exposure with neurologic dysfunction and diseaseMitochondrial ferritin in the substantia nigra in restless legs syndromeMaternal stress modulates the effects of developmental lead exposureSustained exposure to the widely used herbicide atrazine: altered function and loss of neurons in brain monoamine systems.Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.Early environmental origins of neurodegenerative disease in later life.Developmental pesticide models of the Parkinson disease phenotype.Pesticides and Parkinson's disease--is there a link?Mouse models of Parkinson's disease associated with mitochondrial dysfunctionGene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian modelsEnvironmental Exposures and Parkinson's DiseaseS-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson's diseaseParkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and DiagnosisMeeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007Human testing of pesticides: ethical and scientific considerationsGene-environment interactions: key to unraveling the mystery of Parkinson's diseaseEvaluation of neurobehavioral and neuroinflammatory end-points in the post-exposure period in rats sub-acutely exposed to manganeseA prospective analysis of airborne metal exposures and risk of Parkinson disease in the nurses' health study cohortNeurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish EmbryosJNK3 mediates paraquat- and rotenone-induced dopaminergic neuron death.Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10Well-water consumption and Parkinson's disease in rural CaliforniaToxicokinetics and toxicodynamics of paraquat accumulation in mouse brainSynergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia.Suppression of ROS generation by 4,4-diaminodiphenylsulfone in non-phagocytic human diploid fibroblastsCaffeine protects against combined paraquat and maneb-induced dopaminergic neuron degenerationMitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.Toxin-induced models of Parkinson's disease.Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease.Paraquat, but not maneb, induces synucleinopathy and tauopathy in striata of mice through inhibition of proteasomal and autophagic pathwaysManeb-induced dopaminergic neuronal death is not affected by loss of mitochondrial complex I activity: results from primary mesencephalic dopaminergic neurons cultured from individual Ndufs4+/+ and Ndufs4-/- mouse embryos.Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California.Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brainParaoxonase 1, agricultural organophosphate exposure, and Parkinson diseaseFeatures of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity.Early exposure to paraquat sensitizes dopaminergic neurons to subsequent silencing of PINK1 gene expression in mice.The role of environmental exposures in neurodegeneration and neurodegenerative diseases.A guide to neurotoxic animal models of Parkinson's diseaseParaquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3.
P2860
Q24322820-440EB19A-7DF7-4705-834C-E4CE1D04222AQ24531528-76004178-36CD-4665-9AC8-C306758EC2D2Q24634189-CAE35F66-3A0F-4FFF-A96D-B94C472E757FQ24812203-2FBAB00F-FE82-4502-9F48-EF9789C2587FQ24813197-FEA89083-A495-4BB9-AA7C-32C4AFF4E3CAQ24815148-74335268-C12E-4A8B-A4CF-83C75F710BBAQ24815631-ADCDBFEB-7F00-4D50-9B43-3E7F2E81F509Q24815683-412C0EE9-A38B-4909-B51D-9CA9228DE20DQ25257240-23E012D5-B55D-46D0-8E41-8DE2D2CF5E11Q26829851-8C211D8E-565E-40B4-A23E-5E36B3BE9CD1Q26863375-15C0A5DC-A6DD-44B7-9CFE-868DB78BD83EQ28074723-499B61B1-2EA1-4933-A0EE-53A3D15E44A5Q28116512-9D4007AE-13F0-457B-A809-DDBC50B7C952Q28384572-2C9411F3-5475-40D2-8D55-6939F5CE5BB2Q28387116-39455D43-4F7E-4F76-8398-164C64323ABFQ28388450-65A98617-D9A3-4614-9198-A8EC1B69799DQ28388674-B5692A59-65F9-4D9A-A794-8F966EBA4EBDQ28392259-F01EBE1C-3482-4808-BF03-CE7E81BD6D28Q28393626-13099BC1-FB56-4626-B1B7-B85666D88A8BQ29541727-3363C40C-4213-4F86-84B3-4CDD3506007EQ30498929-FC46255B-797D-4B70-8287-F937FB30168AQ33487437-0FDB0F85-A98E-4CD8-97F5-98501D75CEA3Q33563011-1D2AB817-259B-42F0-A61C-F73B42A71A31Q33594065-87920770-948F-423E-A399-4B8CF54AC3E0Q33601778-57116797-410D-48C5-AEE6-9CF11B996001Q33751396-D5872F17-41F5-4C4E-A711-AF26026622AEQ33828847-4EB054DE-25EB-45F4-AB4D-83B9DABF96A8Q33840243-F184A87E-62D9-42EB-B981-6537F8D3B72AQ33844749-E36CFC80-FE8C-44B5-B8E1-ACFBA0162BF6Q34142918-5596BB76-70D6-40BA-9128-398F8B6E2BC4Q34146349-A76E8D5A-0CEF-4715-83BF-48D6BA95A1DEQ34422161-68FB67E5-E0A8-47A1-83A7-76A2C3414E44Q34605203-D22D33B6-231F-4B3D-AE2D-13FBCF0059A7Q34936383-A44D15D0-15A4-43F4-B8FD-00A58CEB1BE0Q35053217-DC16FEC7-015A-486D-96B4-EB6AC7E053A1Q35162073-12238BC9-BE11-49B3-A50B-3F99126A943EQ35479978-02C9F61F-AE7F-4D97-B21B-D40E307B4F3BQ35551001-819EF5AF-40A8-44F5-BBCB-E5692CCBA638Q35603488-9FFB1019-53D7-4676-BD82-68122CE20352Q35651220-1F4B69A7-7C31-49B8-8005-2FFF78100014
P2860
The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The nigrostriatal dopaminergic ...... tions for Parkinson's disease.
@ast
The nigrostriatal dopaminergic ...... tions for Parkinson's disease.
@en
type
label
The nigrostriatal dopaminergic ...... tions for Parkinson's disease.
@ast
The nigrostriatal dopaminergic ...... tions for Parkinson's disease.
@en
prefLabel
The nigrostriatal dopaminergic ...... tions for Parkinson's disease.
@ast
The nigrostriatal dopaminergic ...... tions for Parkinson's disease.
@en
P2093
P1476
The nigrostriatal dopaminergic ...... ations for Parkinson's disease
@en
P2093
D A Cory-Slechta
E K Richfield
M Thiruchelvam
P304
P356
10.1523/JNEUROSCI.20-24-09207.2000
P407
P577
2000-12-01T00:00:00Z